The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin. Issue 7 (July 2018)

• Record Type: Journal Article
• Authors: Lewandowski, Jarosław; Rozwadowska, Natalia; Kolanowski, Tomasz J.; Malcher, Agnieszka; Zimna, Agnieszka; Rugowska, Anna; Fiedorowicz, Katarzyna; Łabędź, Wojciech; Kubaszewski, Łukasz; Chojnacka, Katarzyna; Bednarek-Rajewska, Katarzyna; Majewski, Przemysław; Kurpisz, Maciej
• Is Part Of: Cell transplantation. Volume 27:Issue 7(2018)
• Page Start: 1047
• Page End: 1067
• Publication Date: 2018-07
• Subjects: Cardiac differentiation -- cardiomyocyte maturation -- iPSCs -- skeletal myoblasts -- cardiomyogenesis; Cell transplantation -- Periodicals; Cell Transplantation; Cell transplantation; Electronic journals; Periodicals; Periodicals; 571.638
• DOI: 10.1177/0963689718779346
• Languages: English
• ISSNs: 0963-6897

Abstract

Ischemic heart disease, also known as coronary artery disease (CAD), poses a challenge for regenerative medicine. iPSC technology might lead to a breakthrough due to the possibility of directed cell differentiation delivering a new powerful source of human autologous cardiomyocytes. One of the factors supporting proper cell maturation is in vitro culture duration. In this study, primary human skeletal muscle myoblasts were selected as a myogenic cell type reservoir for genetic iPSC reprogramming. Skeletal muscle myoblasts have similar ontogeny embryogenetic pathways (myoblasts vs. cardiomyocytes), and thus, a greater chance of myocardial development might be expected, with maintenance of acquired myogenic cardiac cell characteristics, from the differentiation process when iPSCs of myoblastoid origin are obtained. Analyses of cell morphological and structural changes, gene expression (cardiac markers), and functional tests (intracellular calcium transients) performed at two in vitro culture time points spanning the early stages of cardiac development (day 20 versus 40 of cell in vitro culture) confirmed the ability of the obtained myogenic cells to acquire adult features of differentiated cardiomyocytes. Prolonged 40-day iPSC-derived cardiomyocytes (iPSC-CMs) revealed progressive cellular hypertrophy; a better-developed contractile apparatus; expression of marker genes similar to human myocardial ventricular cells, including a statistically significant CX43 increase, an MHC isoform switch, and a troponin I isoform transition; more efficient intercellular calcium handling; and a stronger response to β-adrenergic stimulation.